Supplementary Figures and Tables from High Numbers of Circulating CD57&lt;sup&gt;+&lt;/sup&gt; NK Cells Associate with Resistance to HER2-Specific Therapeutic Antibodies in HER2&lt;sup&gt;+&lt;/sup&gt; Primary Breast Cancer